Literature DB >> 24114315

RAD51 135G>C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women.

Ana M Krivokuca1, Emina J Malisic, Jelena D Dobricic, Ksenija V Brotto, Milena R Cavic, Radmila N Jankovic, Zorica I Tomasevic, Mirjana V Brankovic-Magic.   

Abstract

Breast cancer is a complex disease with both genetic and environmental factors involved in its etiology. An important role of polymorphisms in genes involved in DNA repair has been reported related to breast cancer risk. We conducted a case-control study in order to investigate the association of RAD51 135G>C and TP53 Arg72Pro polymorphisms with breast cancer in Serbian women.48 BRCA negative women with breast cancer and family history of breast/ovarian cancer (hereditary group), 107 women with breast cancer but without family history of the disease (sporadic group) and 114 healthy women without a history of the disease (control group) were included. Restriction fragment length polymorphism was used for genotyping. Genotype and allelic frequencies, the odds ratio (OR) and the 95 % confidence interval (CI) were calculated as an estimate of relative risk. The Hardy-Weinberg equilibrium was tested using χ(2) test. Significance was considered for p < 0.05. RAD51 135G>C showed statistically significant association of CC genotype and increased breast cancer risk (OR 10.28, 95 % CI 1.12-94.5) in hereditary group of patients compared to the control group. Regarding the TP53 Arg72Pro, we showed statistical significance for ProPro + ProArg comparing to ArgArg (OR 2.34, 95 %, CI 1.17-4.70) in hereditary compared to sporadic group. RAD51 135G>C contributes to hereditary breast cancer in Serbian population, with CC genotype as a risk factor. We also found that carriers of Pro allele of TP53 codon 72 is related to hereditary cancer comparing to sporadic one, which indicates it as a potential risk factor for hereditary form of disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24114315     DOI: 10.1007/s10689-013-9690-3

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  29 in total

1.  RAD51 G135C polymorphism is associated with breast cancer susceptibility: a meta-analysis involving 22,399 subjects.

Authors:  Haiming Sun; Jing Bai; Feng Chen; Yan Jin; Yang Yu; Lianhong Jin; Songbin Fu
Journal:  Breast Cancer Res Treat       Date:  2010-05-08       Impact factor: 4.872

2.  RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.

Authors:  Lin-Bo Gao; Xin-Min Pan; Li-Juan Li; Wei-Bo Liang; Yi Zhu; Lu-Shun Zhang; Yong-Gang Wei; Ming Tang; Lin Zhang
Journal:  Breast Cancer Res Treat       Date:  2010-07-17       Impact factor: 4.872

Review 3.  Breast cancer susceptibility and the DNA damage response.

Authors:  Vesna Dapic; Marcelo A Carvalho; Alvaro N A Monteiro
Journal:  Cancer Control       Date:  2005-04       Impact factor: 3.302

4.  Identification of Rad51 alteration in patients with bilateral breast cancer.

Authors:  M Kato; K Yano; F Matsuo; H Saito; T Katagiri; H Kurumizaka; M Yoshimoto; F Kasumi; F Akiyama; G Sakamoto; H Nagawa; Y Nakamura; Y Miki
Journal:  J Hum Genet       Date:  2000       Impact factor: 3.172

Review 5.  RAD51, genomic stability, and tumorigenesis.

Authors:  Christine Richardson
Journal:  Cancer Lett       Date:  2005-02-10       Impact factor: 8.679

6.  DNA double-strand break signaling and human disorders.

Authors:  Toshiyuki Bohgaki; Miyuki Bohgaki; Razqallah Hakem
Journal:  Genome Integr       Date:  2010-11-05

7.  The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi women.

Authors:  Abeer Al-Qasem; Mohamed Toulimat; Asma Tulbah; Naser Elkum; Taher Al-Tweigeri; Abdelilah Aboussekhra
Journal:  Oncol Lett       Date:  2012-01-24       Impact factor: 2.967

Review 8.  p53 polymorphisms: cancer implications.

Authors:  Catherine Whibley; Paul D P Pharoah; Monica Hollstein
Journal:  Nat Rev Cancer       Date:  2009-02       Impact factor: 60.716

9.  Variation in the RAD51 gene and familial breast cancer.

Authors:  Felicity Lose; Paul Lovelock; Georgia Chenevix-Trench; Graham J Mann; Gulietta M Pupo; Amanda B Spurdle
Journal:  Breast Cancer Res       Date:  2006-06-08       Impact factor: 6.466

10.  Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls.

Authors:  Olivia Fletcher; Nichola Johnson; Isabel Dos Santos Silva; Outi Kilpivaara; Kristiina Aittomäki; Carl Blomqvist; Heli Nevanlinna; Marijke Wasielewski; Hanne Meijers-Heijerboer; Annegien Broeks; Marjanka K Schmidt; Laura J Van't Veer; Michael Bremer; Thilo Dörk; Elena V Chekmariova; Anna P Sokolenko; Evgeny N Imyanitov; Ute Hamann; Muhammad U Rashid; Hiltrud Brauch; Christina Justenhoven; Alan Ashworth; Julian Peto
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

View more
  7 in total

1.  Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls.

Authors:  Bei-Bei Zhang; Dao-Gang Wang; Chao Xuan; Gui-Li Sun; Kai-Feng Deng
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

2.  Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.

Authors:  Zhenzhen Wu; Peng Wang; Chunhua Song; Kaijuan Wang; Rui Yan; Jingruo Li; Liping Dai
Journal:  Mol Genet Genomics       Date:  2015-01-09       Impact factor: 3.291

3.  RAD51 135G>C substitution increases breast cancer risk in an ethnic-specific manner: a meta-analysis on 21,236 cases and 19,407 controls.

Authors:  Deepa Sekhar; Singh Pooja; Sandeep Kumar; Singh Rajender
Journal:  Sci Rep       Date:  2015-06-25       Impact factor: 4.379

4.  Single Nucleotide Polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T Homologous Recombination Repair Genes and the Risk of Triple- Negative Breast Cancer in Polish Women.

Authors:  Magdalena M Michalska; Dariusz Samulak; Hanna Romanowicz; Beata Smolarz
Journal:  Pathol Oncol Res       Date:  2015-03-07       Impact factor: 3.201

5.  p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies.

Authors:  Brehima Diakite; Yaya Kassogue; Guimogo Dolo; Jun Wang; Erin Neuschler; Oumar Kassogue; Mamadou L Keita; Cheick B Traore; Bakarou Kamate; Etienne Dembele; Sellama Nadifi; Robert L Murphy; Seydou Doumbia; Lifang Hou; Mamoudou Maiga
Journal:  BMC Med Genet       Date:  2020-10-19       Impact factor: 2.103

6.  Association of polymorphisms in the 5' untranslated region of RAD51 gene with risk of endometrial cancer in the Polish population.

Authors:  Magdalena M Michalska; Dariusz Samulak; Hanna Romanowicz; Beata Smolarz
Journal:  Arch Gynecol Obstet       Date:  2014-06-15       Impact factor: 2.344

7.  Polymorphisms in RAD51 and their relation with breast cancer in Saudi females.

Authors:  Sahar Tulbah; Huda Alabdulkarim; Mohammad Alanazi; Narasimha Reddy Parine; Jilani Shaik; Akbar Ali Khan Pathan; Abdullah Al-Amri; Wajahatullah Khan; Arjumand Warsy
Journal:  Onco Targets Ther       Date:  2016-01-11       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.